• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Certara releases new version of informatics platform D360

Certara releases new version of informatics platform D360

January 31, 2017
CenterWatch Staff

Certara, a provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, has released D360 version 9.0 along with D360 Express, its data informatics platform for discovery scientists. D360 is a self-service data access, integration and visualization solution used to query multiple cheminformatics and bioinformatics data sources and make informed go/no-go and next step research decisions. It is used by more than 5,000 scientists worldwide at both large pharma and specialty research organizations.

“Scientists choose D360 because it allows them to accelerate their ‘time to insight.’ It enables them to access current data faster, spend more time on analysis, and ask and answer questions ‘on the fly,’” said Certara Senior Director, Product Management David Lowis, D. Phil. “To that end, version 9 offers ‘virtual compound support,’ an exciting new capability that allows users to create new chemical structure ideas that can be assessed, shared and prioritized alongside existing project compounds extending D360’s capabilities from pure analysis into the world of design. D360’s upgraded data query and handling capabilities also allow users to investigate more complex assays and study results, an expertise that will increasingly be needed as the industry moves further into precision medicine.”

Certara’s D360 is a scientific informatics platform for integrating and leveraging the large amounts of diverse scientific data generated in discovery research. D360 enables scientists to cut dramatically the time required to provision data. They estimate that this change allows them to increase by more than 50% the time they spend performing pivotal scientific modeling and analysis, advancing compounds, and making informed decisions. 

D360 version 9 and D360 Express offer several new features, including the following:

  • Virtual Compound Capabilities—D360 now provides full support for virtual compounds—chemical structures not available in source systems. Compounds can be added to datasets from external sources or from a sketch. New chemical structure ideas can be shared, assessed and prioritized alongside known test entities.
  • Complex Assay Data Handling—Data query capabilities have been extended scientifically to handle more complex assays to be evaluated for new research initiatives including precision medicine.
  • Enhanced Performance—D360’s greatest strength is that it allows scientists to access their data quickly and easily and to move swiftly to action. Certara has improved all aspects of D360 performance, including data queries, data formatting and analysis, response to ad hoc questions, and handling of large and/or complex datasets. Faster data retrieval and enhanced query features allow scientists to more readily mine corporate data for scientific insight rather than relying on specific data feeds.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing